Incidence of HCV infection in French hemodialysis units: a prospective study.
A large prospective study was carried out from 1997 to 2000 in 25 French hemodialysis units including 1,323 patients to determine the incidence of hepatitis C virus (HCV) infection. Monthly testing of alanine aminotransferase (ALT) activity, and assessment of HCV RNA and anti-HCV antibodies if the ALT activity was elevated, identified 14 new infections in 7 different units, giving an incidence of 0.4% new HCV infections per year. Molecular analyses and epidemiological data indicated that five patients became infected with HCV outside the unit where they were dialyzed, while the nine remaining patients acquired HCV from infected patients on dialysis during the same shift at the same unit. HCV was cleared in six of the seven (85.7%) patients with acute hepatitis C who were given standard doses of alpha-interferon (alpha-IFN). The persistence of nosocomial transmission of HCV in hemodialysis units emphasizes the need to implement infection control practices. Identifying new infections is crucial because alpha-IFN treatment results in long term clearance of HCV RNA in a large proportion of patients.
Izopet
Jacques
J
Laboratoire de Virologie, Variabilité virale EA2046-IFR30, Hôpital Purpan, CHU Toulouse, France. izopet.j@chu-toulouse.fr
Sandres-Sauné
Karine
K
Kamar
Nassim
N
Salama
Gilles
G
Dubois
Martine
M
Pasquier
Christophe
C
Rostaing
Lionel
L
D000208:Acute Disease; D000410:Alanine Transaminase / Q000097:blood / Q000378:metabolism; D006436:Hemodialysis Units, Hospital; D016174:Hepacivirus; D006526:Hepatitis C / Q000097:blood / Q000453:epidemiology*; D006801:Humans; D010802:Phylogeny; D015995:Prevalence; D011446:Prospective Studies; D012367:RNA, Viral / Q000097:blood*
D012367:RNA, Viral; D000410:Alanine Transaminase